enterococcus spp against s aureus atcc 43300 mrsa Search Results


atcc 43300  (ATCC)
99
ATCC atcc 43300
Atcc 43300, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enterococcus+spp+against+s+aureus+atcc+43300+mrsa/Staphylococcus+aureus+subsp%2E+aureus+Rosenbach/pmc04364681-302-11-11
Average 99 stars, based on 1 article reviews
atcc 43300 - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
gram positive  (ATCC)
99
ATCC gram positive
Gram Positive, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enterococcus+spp+against+s+aureus+atcc+43300+mrsa/Staphylococcus+aureus+subsp%2E+aureus+Rosenbach/pmc07040619-11-12-13
Average 99 stars, based on 1 article reviews
gram positive - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
indicator pathogens e coli atcc 25922 s aureus atcc 43300 p aeruginosa atcc 27853 c albicans atcc 64124 r11 20 33  (ATCC)
99
ATCC indicator pathogens e coli atcc 25922 s aureus atcc 43300 p aeruginosa atcc 27853 c albicans atcc 64124 r11 20 33
Indicator Pathogens E Coli Atcc 25922 S Aureus Atcc 43300 P Aeruginosa Atcc 27853 C Albicans Atcc 64124 R11 20 33, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enterococcus+spp+against+s+aureus+atcc+43300+mrsa/Escherichia+coli/10__5897_slash_ajmr2024__9742-124-6-10
Average 99 stars, based on 1 article reviews
indicator pathogens e coli atcc 25922 s aureus atcc 43300 p aeruginosa atcc 27853 c albicans atcc 64124 r11 20 33 - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
mic against mrsa atcc  (ATCC)
97
ATCC mic against mrsa atcc
In vitro antimicrobial bioassay of actinomycetia extracts against model pathogens and MDR pathogens: ( A ) Antimicrobial activity by spot inoculation (I,II) and well diffusion method (III–V) against model pathogens: (I) Candida albicans (MTCC 227). (II,III) <t>MRSA</t> (ATCC 43300). (IV) Klebsiella pneumonia (MTCC 3384); (V) Pseudomonas aeruginosa (MTCC 741). ( B ) Bioactivity of fermentation broth of actinomycetia isolates against model pathogens, based on triplicate experiments. ( C ) Antimicrobial activity by well diffusion method against MDR pathogens: (I,II) Pseudomonas aeruginosa . (III–V) Enterococcus faecalis . (VI–VIII) Escherichia coli . ( D ) Bioactivity of fermentation broth of actinomycetia isolates against 3 MDR pathogens, based on triplicate experiments, against: GNR7; Enterococcus faecalis ; GNR18; Pseudomonas aeruginosa ; and GNR19; Escherichia coli .
Mic Against Mrsa Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enterococcus+spp+against+s+aureus+atcc+43300+mrsa/Staphylococcus+aureus/pmc10456813-373-10-13
Average 97 stars, based on 1 article reviews
mic against mrsa atcc - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier
mrsa atcc 43300  (ATCC)
99
ATCC mrsa atcc 43300
In vitro antimicrobial bioassay of actinomycetia extracts against model pathogens and MDR pathogens: ( A ) Antimicrobial activity by spot inoculation (I,II) and well diffusion method (III–V) against model pathogens: (I) Candida albicans (MTCC 227). (II,III) <t>MRSA</t> (ATCC 43300). (IV) Klebsiella pneumonia (MTCC 3384); (V) Pseudomonas aeruginosa (MTCC 741). ( B ) Bioactivity of fermentation broth of actinomycetia isolates against model pathogens, based on triplicate experiments. ( C ) Antimicrobial activity by well diffusion method against MDR pathogens: (I,II) Pseudomonas aeruginosa . (III–V) Enterococcus faecalis . (VI–VIII) Escherichia coli . ( D ) Bioactivity of fermentation broth of actinomycetia isolates against 3 MDR pathogens, based on triplicate experiments, against: GNR7; Enterococcus faecalis ; GNR18; Pseudomonas aeruginosa ; and GNR19; Escherichia coli .
Mrsa Atcc 43300, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enterococcus+spp+against+s+aureus+atcc+43300+mrsa/Staphylococcus+aureus%3B+subsp%2E+aureus/pm41683342-142-15-16
Average 99 stars, based on 1 article reviews
mrsa atcc 43300 - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
bacteria  (ATCC)
99
ATCC bacteria
In vitro antimicrobial bioassay of actinomycetia extracts against model pathogens and MDR pathogens: ( A ) Antimicrobial activity by spot inoculation (I,II) and well diffusion method (III–V) against model pathogens: (I) Candida albicans (MTCC 227). (II,III) <t>MRSA</t> (ATCC 43300). (IV) Klebsiella pneumonia (MTCC 3384); (V) Pseudomonas aeruginosa (MTCC 741). ( B ) Bioactivity of fermentation broth of actinomycetia isolates against model pathogens, based on triplicate experiments. ( C ) Antimicrobial activity by well diffusion method against MDR pathogens: (I,II) Pseudomonas aeruginosa . (III–V) Enterococcus faecalis . (VI–VIII) Escherichia coli . ( D ) Bioactivity of fermentation broth of actinomycetia isolates against 3 MDR pathogens, based on triplicate experiments, against: GNR7; Enterococcus faecalis ; GNR18; Pseudomonas aeruginosa ; and GNR19; Escherichia coli .
Bacteria, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enterococcus+spp+against+s+aureus+atcc+43300+mrsa/Bacteria/pmc06021643-200-14-18
Average 99 stars, based on 1 article reviews
bacteria - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
time kill assays against s aureus atcc 25923  (ATCC)
99
ATCC time kill assays against s aureus atcc 25923
In vitro antimicrobial bioassay of actinomycetia extracts against model pathogens and MDR pathogens: ( A ) Antimicrobial activity by spot inoculation (I,II) and well diffusion method (III–V) against model pathogens: (I) Candida albicans (MTCC 227). (II,III) <t>MRSA</t> (ATCC 43300). (IV) Klebsiella pneumonia (MTCC 3384); (V) Pseudomonas aeruginosa (MTCC 741). ( B ) Bioactivity of fermentation broth of actinomycetia isolates against model pathogens, based on triplicate experiments. ( C ) Antimicrobial activity by well diffusion method against MDR pathogens: (I,II) Pseudomonas aeruginosa . (III–V) Enterococcus faecalis . (VI–VIII) Escherichia coli . ( D ) Bioactivity of fermentation broth of actinomycetia isolates against 3 MDR pathogens, based on triplicate experiments, against: GNR7; Enterococcus faecalis ; GNR18; Pseudomonas aeruginosa ; and GNR19; Escherichia coli .
Time Kill Assays Against S Aureus Atcc 25923, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enterococcus+spp+against+s+aureus+atcc+43300+mrsa/Staphylococcus+aureus%3B+subsp%2E+aureus/pmc11124336-94-8-13
Average 99 stars, based on 1 article reviews
time kill assays against s aureus atcc 25923 - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
s aureus strains  (ATCC)
95
ATCC s aureus strains
In vitro antimicrobial bioassay of actinomycetia extracts against model pathogens and MDR pathogens: ( A ) Antimicrobial activity by spot inoculation (I,II) and well diffusion method (III–V) against model pathogens: (I) Candida albicans (MTCC 227). (II,III) <t>MRSA</t> (ATCC 43300). (IV) Klebsiella pneumonia (MTCC 3384); (V) Pseudomonas aeruginosa (MTCC 741). ( B ) Bioactivity of fermentation broth of actinomycetia isolates against model pathogens, based on triplicate experiments. ( C ) Antimicrobial activity by well diffusion method against MDR pathogens: (I,II) Pseudomonas aeruginosa . (III–V) Enterococcus faecalis . (VI–VIII) Escherichia coli . ( D ) Bioactivity of fermentation broth of actinomycetia isolates against 3 MDR pathogens, based on triplicate experiments, against: GNR7; Enterococcus faecalis ; GNR18; Pseudomonas aeruginosa ; and GNR19; Escherichia coli .
S Aureus Strains, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enterococcus+spp+against+s+aureus+atcc+43300+mrsa/Staphylococcus+aureus+subsp%2E+aureus+Rosenbach/pmc08341851-198-21-27
Average 95 stars, based on 1 article reviews
s aureus strains - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier
common foodborne pathogens  (ATCC)
96
ATCC common foodborne pathogens
In vitro antimicrobial bioassay of actinomycetia extracts against model pathogens and MDR pathogens: ( A ) Antimicrobial activity by spot inoculation (I,II) and well diffusion method (III–V) against model pathogens: (I) Candida albicans (MTCC 227). (II,III) <t>MRSA</t> (ATCC 43300). (IV) Klebsiella pneumonia (MTCC 3384); (V) Pseudomonas aeruginosa (MTCC 741). ( B ) Bioactivity of fermentation broth of actinomycetia isolates against model pathogens, based on triplicate experiments. ( C ) Antimicrobial activity by well diffusion method against MDR pathogens: (I,II) Pseudomonas aeruginosa . (III–V) Enterococcus faecalis . (VI–VIII) Escherichia coli . ( D ) Bioactivity of fermentation broth of actinomycetia isolates against 3 MDR pathogens, based on triplicate experiments, against: GNR7; Enterococcus faecalis ; GNR18; Pseudomonas aeruginosa ; and GNR19; Escherichia coli .
Common Foodborne Pathogens, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enterococcus+spp+against+s+aureus+atcc+43300+mrsa/Escherichia+coli+o157%3Ah7/pmc12291754-114-36-44
Average 96 stars, based on 1 article reviews
common foodborne pathogens - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
atcc test organisms  (ATCC)
99
ATCC atcc test organisms
In vitro antimicrobial bioassay of actinomycetia extracts against model pathogens and MDR pathogens: ( A ) Antimicrobial activity by spot inoculation (I,II) and well diffusion method (III–V) against model pathogens: (I) Candida albicans (MTCC 227). (II,III) <t>MRSA</t> (ATCC 43300). (IV) Klebsiella pneumonia (MTCC 3384); (V) Pseudomonas aeruginosa (MTCC 741). ( B ) Bioactivity of fermentation broth of actinomycetia isolates against model pathogens, based on triplicate experiments. ( C ) Antimicrobial activity by well diffusion method against MDR pathogens: (I,II) Pseudomonas aeruginosa . (III–V) Enterococcus faecalis . (VI–VIII) Escherichia coli . ( D ) Bioactivity of fermentation broth of actinomycetia isolates against 3 MDR pathogens, based on triplicate experiments, against: GNR7; Enterococcus faecalis ; GNR18; Pseudomonas aeruginosa ; and GNR19; Escherichia coli .
Atcc Test Organisms, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enterococcus+spp+against+s+aureus+atcc+43300+mrsa/Klebsiella+quasipneumoniae+Brisse+et+al/10__3126_slash_tujm__v12i1__88323-56-17-17
Average 99 stars, based on 1 article reviews
atcc test organisms - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
mrsa strains  (ATCC)
95
ATCC mrsa strains
In vitro antimicrobial bioassay of actinomycetia extracts against model pathogens and MDR pathogens: ( A ) Antimicrobial activity by spot inoculation (I,II) and well diffusion method (III–V) against model pathogens: (I) Candida albicans (MTCC 227). (II,III) <t>MRSA</t> (ATCC 43300). (IV) Klebsiella pneumonia (MTCC 3384); (V) Pseudomonas aeruginosa (MTCC 741). ( B ) Bioactivity of fermentation broth of actinomycetia isolates against model pathogens, based on triplicate experiments. ( C ) Antimicrobial activity by well diffusion method against MDR pathogens: (I,II) Pseudomonas aeruginosa . (III–V) Enterococcus faecalis . (VI–VIII) Escherichia coli . ( D ) Bioactivity of fermentation broth of actinomycetia isolates against 3 MDR pathogens, based on triplicate experiments, against: GNR7; Enterococcus faecalis ; GNR18; Pseudomonas aeruginosa ; and GNR19; Escherichia coli .
Mrsa Strains, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enterococcus+spp+against+s+aureus+atcc+43300+mrsa/Staphylococcus+aureus+Rosenbach/pm38257351-202-12-14
Average 95 stars, based on 1 article reviews
mrsa strains - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

Image Search Results


In vitro antimicrobial bioassay of actinomycetia extracts against model pathogens and MDR pathogens: ( A ) Antimicrobial activity by spot inoculation (I,II) and well diffusion method (III–V) against model pathogens: (I) Candida albicans (MTCC 227). (II,III) MRSA (ATCC 43300). (IV) Klebsiella pneumonia (MTCC 3384); (V) Pseudomonas aeruginosa (MTCC 741). ( B ) Bioactivity of fermentation broth of actinomycetia isolates against model pathogens, based on triplicate experiments. ( C ) Antimicrobial activity by well diffusion method against MDR pathogens: (I,II) Pseudomonas aeruginosa . (III–V) Enterococcus faecalis . (VI–VIII) Escherichia coli . ( D ) Bioactivity of fermentation broth of actinomycetia isolates against 3 MDR pathogens, based on triplicate experiments, against: GNR7; Enterococcus faecalis ; GNR18; Pseudomonas aeruginosa ; and GNR19; Escherichia coli .

Journal: Metabolites

Article Title: Potentiality of Actinomycetia Prevalent in Selected Forest Ecosystems in Assam, India to Combat Multi-Drug-Resistant Microbial Pathogens

doi: 10.3390/metabo13080911

Figure Lengend Snippet: In vitro antimicrobial bioassay of actinomycetia extracts against model pathogens and MDR pathogens: ( A ) Antimicrobial activity by spot inoculation (I,II) and well diffusion method (III–V) against model pathogens: (I) Candida albicans (MTCC 227). (II,III) MRSA (ATCC 43300). (IV) Klebsiella pneumonia (MTCC 3384); (V) Pseudomonas aeruginosa (MTCC 741). ( B ) Bioactivity of fermentation broth of actinomycetia isolates against model pathogens, based on triplicate experiments. ( C ) Antimicrobial activity by well diffusion method against MDR pathogens: (I,II) Pseudomonas aeruginosa . (III–V) Enterococcus faecalis . (VI–VIII) Escherichia coli . ( D ) Bioactivity of fermentation broth of actinomycetia isolates against 3 MDR pathogens, based on triplicate experiments, against: GNR7; Enterococcus faecalis ; GNR18; Pseudomonas aeruginosa ; and GNR19; Escherichia coli .

Article Snippet: Recently, similar findings were reported, where EA-Kz-24 exhibited the lowest MIC against MRSA ATCC 43,300 and Candida albicans MTCC 227 (0.024 μg/mL) [ ].

Techniques: In Vitro, Bioassay, Activity Assay, Diffusion-based Assay

MIC (µg/mL) of the ethyl acetate extract of three potent actinomycetia strains by broth dilution method.

Journal: Metabolites

Article Title: Potentiality of Actinomycetia Prevalent in Selected Forest Ecosystems in Assam, India to Combat Multi-Drug-Resistant Microbial Pathogens

doi: 10.3390/metabo13080911

Figure Lengend Snippet: MIC (µg/mL) of the ethyl acetate extract of three potent actinomycetia strains by broth dilution method.

Article Snippet: Recently, similar findings were reported, where EA-Kz-24 exhibited the lowest MIC against MRSA ATCC 43,300 and Candida albicans MTCC 227 (0.024 μg/mL) [ ].

Techniques: Bacteria